2024-04-01 2025-03-31 2025-03-31 false 11258426 VORLON RESEARCH LIMITED 2025-09-04 82990 false iso4217:GBP xbrli:pure 11258426 2024-03-31 11258426 2025-03-31 11258426 2024-04-01 2025-03-31 11258426 2023-03-31 11258426 2024-03-31 11258426 2023-04-01 2024-03-31 11258426 bus:SmallEntities 2024-04-01 2025-03-31 11258426 bus:AuditExempt-NoAccountantsReport 2024-04-01 2025-03-31 11258426 bus:FullAccounts 2024-04-01 2025-03-31 11258426 bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 11258426 core:WithinOneYear 2025-03-31 11258426 core:AfterOneYear 2025-03-31 11258426 core:WithinOneYear 2024-03-31 11258426 core:AfterOneYear 2024-03-31 11258426 core:ShareCapital 2025-03-31 11258426 core:SharePremium 2025-03-31 11258426 core:RevaluationReserve 2025-03-31 11258426 core:OtherReservesSubtotal 2025-03-31 11258426 core:RetainedEarningsAccumulatedLosses 2025-03-31 11258426 core:ShareCapital 2024-03-31 11258426 core:SharePremium 2024-03-31 11258426 core:RevaluationReserve 2024-03-31 11258426 core:OtherReservesSubtotal 2024-03-31 11258426 core:RetainedEarningsAccumulatedLosses 2024-03-31 11258426 core:LandBuildings 2025-03-31 11258426 core:PlantMachinery 2025-03-31 11258426 core:Vehicles 2025-03-31 11258426 core:FurnitureFittings 2025-03-31 11258426 core:OfficeEquipment 2025-03-31 11258426 core:NetGoodwill 2025-03-31 11258426 core:IntangibleAssetsOtherThanGoodwill 2025-03-31 11258426 core:ListedExchangeTraded 2025-03-31 11258426 core:UnlistedNon-exchangeTraded 2025-03-31 11258426 core:LandBuildings 2024-03-31 11258426 core:PlantMachinery 2024-03-31 11258426 core:Vehicles 2024-03-31 11258426 core:FurnitureFittings 2024-03-31 11258426 core:OfficeEquipment 2024-03-31 11258426 core:NetGoodwill 2024-03-31 11258426 core:IntangibleAssetsOtherThanGoodwill 2024-03-31 11258426 core:ListedExchangeTraded 2024-03-31 11258426 core:UnlistedNon-exchangeTraded 2024-03-31 11258426 core:LandBuildings 2024-04-01 2025-03-31 11258426 core:PlantMachinery 2024-04-01 2025-03-31 11258426 core:Vehicles 2024-04-01 2025-03-31 11258426 core:FurnitureFittings 2024-04-01 2025-03-31 11258426 core:OfficeEquipment 2024-04-01 2025-03-31 11258426 core:NetGoodwill 2024-04-01 2025-03-31 11258426 core:IntangibleAssetsOtherThanGoodwill 2024-04-01 2025-03-31 11258426 core:ListedExchangeTraded 2024-04-01 2025-03-31 11258426 core:UnlistedNon-exchangeTraded 2024-04-01 2025-03-31 11258426 core:MoreThanFiveYears 2024-04-01 2025-03-31 11258426 core:Non-currentFinancialInstruments 2025-03-31 11258426 core:Non-currentFinancialInstruments 2024-03-31 11258426 dpl:CostSales 2024-04-01 2025-03-31 11258426 dpl:DistributionCosts 2024-04-01 2025-03-31 11258426 core:LandBuildings 2024-04-01 2025-03-31 11258426 core:PlantMachinery 2024-04-01 2025-03-31 11258426 core:Vehicles 2024-04-01 2025-03-31 11258426 core:FurnitureFittings 2024-04-01 2025-03-31 11258426 core:OfficeEquipment 2024-04-01 2025-03-31 11258426 dpl:AdministrativeExpenses 2024-04-01 2025-03-31 11258426 core:NetGoodwill 2024-04-01 2025-03-31 11258426 core:IntangibleAssetsOtherThanGoodwill 2024-04-01 2025-03-31 11258426 dpl:GroupUndertakings 2024-04-01 2025-03-31 11258426 dpl:ParticipatingInterests 2024-04-01 2025-03-31 11258426 dpl:GroupUndertakings core:ListedExchangeTraded 2024-04-01 2025-03-31 11258426 core:ListedExchangeTraded 2024-04-01 2025-03-31 11258426 dpl:GroupUndertakings core:UnlistedNon-exchangeTraded 2024-04-01 2025-03-31 11258426 core:UnlistedNon-exchangeTraded 2024-04-01 2025-03-31 11258426 dpl:CostSales 2023-04-01 2024-03-31 11258426 dpl:DistributionCosts 2023-04-01 2024-03-31 11258426 core:LandBuildings 2023-04-01 2024-03-31 11258426 core:PlantMachinery 2023-04-01 2024-03-31 11258426 core:Vehicles 2023-04-01 2024-03-31 11258426 core:FurnitureFittings 2023-04-01 2024-03-31 11258426 core:OfficeEquipment 2023-04-01 2024-03-31 11258426 dpl:AdministrativeExpenses 2023-04-01 2024-03-31 11258426 core:NetGoodwill 2023-04-01 2024-03-31 11258426 core:IntangibleAssetsOtherThanGoodwill 2023-04-01 2024-03-31 11258426 dpl:GroupUndertakings 2023-04-01 2024-03-31 11258426 dpl:ParticipatingInterests 2023-04-01 2024-03-31 11258426 dpl:GroupUndertakings core:ListedExchangeTraded 2023-04-01 2024-03-31 11258426 core:ListedExchangeTraded 2023-04-01 2024-03-31 11258426 dpl:GroupUndertakings core:UnlistedNon-exchangeTraded 2023-04-01 2024-03-31 11258426 core:UnlistedNon-exchangeTraded 2023-04-01 2024-03-31 11258426 core:NetGoodwill 2025-03-31 11258426 core:IntangibleAssetsOtherThanGoodwill 2025-03-31 11258426 core:LandBuildings 2025-03-31 11258426 core:PlantMachinery 2025-03-31 11258426 core:Vehicles 2025-03-31 11258426 core:FurnitureFittings 2025-03-31 11258426 core:OfficeEquipment 2025-03-31 11258426 core:AfterOneYear 2025-03-31 11258426 core:WithinOneYear 2025-03-31 11258426 core:ListedExchangeTraded 2025-03-31 11258426 core:UnlistedNon-exchangeTraded 2025-03-31 11258426 core:ShareCapital 2025-03-31 11258426 core:SharePremium 2025-03-31 11258426 core:RevaluationReserve 2025-03-31 11258426 core:OtherReservesSubtotal 2025-03-31 11258426 core:RetainedEarningsAccumulatedLosses 2025-03-31 11258426 core:NetGoodwill 2024-03-31 11258426 core:IntangibleAssetsOtherThanGoodwill 2024-03-31 11258426 core:LandBuildings 2024-03-31 11258426 core:PlantMachinery 2024-03-31 11258426 core:Vehicles 2024-03-31 11258426 core:FurnitureFittings 2024-03-31 11258426 core:OfficeEquipment 2024-03-31 11258426 core:AfterOneYear 2024-03-31 11258426 core:WithinOneYear 2024-03-31 11258426 core:ListedExchangeTraded 2024-03-31 11258426 core:UnlistedNon-exchangeTraded 2024-03-31 11258426 core:ShareCapital 2024-03-31 11258426 core:SharePremium 2024-03-31 11258426 core:RevaluationReserve 2024-03-31 11258426 core:OtherReservesSubtotal 2024-03-31 11258426 core:RetainedEarningsAccumulatedLosses 2024-03-31 11258426 core:NetGoodwill 2023-03-31 11258426 core:IntangibleAssetsOtherThanGoodwill 2023-03-31 11258426 core:LandBuildings 2023-03-31 11258426 core:PlantMachinery 2023-03-31 11258426 core:Vehicles 2023-03-31 11258426 core:FurnitureFittings 2023-03-31 11258426 core:OfficeEquipment 2023-03-31 11258426 core:AfterOneYear 2023-03-31 11258426 core:WithinOneYear 2023-03-31 11258426 core:ListedExchangeTraded 2023-03-31 11258426 core:UnlistedNon-exchangeTraded 2023-03-31 11258426 core:ShareCapital 2023-03-31 11258426 core:SharePremium 2023-03-31 11258426 core:RevaluationReserve 2023-03-31 11258426 core:OtherReservesSubtotal 2023-03-31 11258426 core:RetainedEarningsAccumulatedLosses 2023-03-31 11258426 core:AfterOneYear 2024-04-01 2025-03-31 11258426 core:WithinOneYear 2024-04-01 2025-03-31 11258426 core:Non-currentFinancialInstruments core:CostValuation 2024-04-01 2025-03-31 11258426 core:Non-currentFinancialInstruments core:AdditionsToInvestments 2024-04-01 2025-03-31 11258426 core:Non-currentFinancialInstruments core:RevaluationsIncreaseDecreaseInInvestments 2024-04-01 2025-03-31 11258426 core:Non-currentFinancialInstruments core:DisposalsDecreaseInInvestments 2024-04-01 2025-03-31 11258426 core:Non-currentFinancialInstruments core:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments 2024-04-01 2025-03-31 11258426 core:Non-currentFinancialInstruments core:ImpairmentLossReversalProvisionsForImpairmentInvestments 2024-04-01 2025-03-31 11258426 core:Non-currentFinancialInstruments core:AcquisitionsIncreaseInProvisionsForImpairmentInvestments 2024-04-01 2025-03-31 11258426 core:Non-currentFinancialInstruments core:DisposalsDecreaseInProvisionsForImpairmentInvestments 2024-04-01 2025-03-31 11258426 core:Non-currentFinancialInstruments core:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments 2024-04-01 2025-03-31 11258426 core:Non-currentFinancialInstruments core:CostValuation 2025-03-31 11258426 core:Non-currentFinancialInstruments core:AdditionsToInvestments 2025-03-31 11258426 core:Non-currentFinancialInstruments core:RevaluationsIncreaseDecreaseInInvestments 2025-03-31 11258426 core:Non-currentFinancialInstruments core:DisposalsDecreaseInInvestments 2025-03-31 11258426 core:Non-currentFinancialInstruments core:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments 2025-03-31 11258426 core:Non-currentFinancialInstruments core:ImpairmentLossReversalProvisionsForImpairmentInvestments 2025-03-31 11258426 core:Non-currentFinancialInstruments core:AcquisitionsIncreaseInProvisionsForImpairmentInvestments 2025-03-31 11258426 core:Non-currentFinancialInstruments core:DisposalsDecreaseInProvisionsForImpairmentInvestments 2025-03-31 11258426 core:Non-currentFinancialInstruments core:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments 2025-03-31 11258426 core:Non-currentFinancialInstruments core:CostValuation 2024-03-31 11258426 core:Non-currentFinancialInstruments core:AdditionsToInvestments 2024-03-31 11258426 core:Non-currentFinancialInstruments core:RevaluationsIncreaseDecreaseInInvestments 2024-03-31 11258426 core:Non-currentFinancialInstruments core:DisposalsDecreaseInInvestments 2024-03-31 11258426 core:Non-currentFinancialInstruments core:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments 2024-03-31 11258426 core:Non-currentFinancialInstruments core:ImpairmentLossReversalProvisionsForImpairmentInvestments 2024-03-31 11258426 core:Non-currentFinancialInstruments core:AcquisitionsIncreaseInProvisionsForImpairmentInvestments 2024-03-31 11258426 core:Non-currentFinancialInstruments core:DisposalsDecreaseInProvisionsForImpairmentInvestments 2024-03-31 11258426 core:Non-currentFinancialInstruments core:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments 2024-03-31 11258426 bus:Director1 2024-04-01 2025-03-31 11258426 bus:Director2 2024-04-01 2025-03-31

VORLON RESEARCH LIMITED

Registered Number
11258426
(England and Wales)

Unaudited Financial Statements for the Year ended
31 March 2025

VORLON RESEARCH LIMITED
Company Information
for the year from 1 April 2024 to 31 March 2025

Directors | Darryl Miles Cassingham
| Maria Cassingham

Registered Address | Ruskin House
| Church Road
| Bradford Abbas
| DT9 6RF

Registered Number | 11258426 (England and Wales)

VORLON RESEARCH LIMITED
Balance Sheet as at
31 March 2025

| Notes | 2025 |  | 2024
--- | --- | --- | --- | ---
|  | £ |  | £ |  | £ |  | £
Fixed assets |  |  |  |  |  |  |  |
Tangible assets | 3 |  |  | 151,198 |  |  |  | 118,442
|  |  |  | 151,198 |  |  |  | 118,442
Current assets |  |  |  |  |  |  |  |
Debtors | 4 | 205,221 |  |  |  | 61,247 |  |
Cash at bank and on hand |  | 202,057 |  |  |  | 525,359 |  |
|  | 407,278 |  |  |  | 586,606 |  |
Creditors amounts falling due within one year | 5 | (41,966) |  |  |  | (53,714) |  |
Net current assets (liabilities) |  |  |  | 365,312 |  |  |  | 532,892
Total assets less current liabilities |  |  |  | 516,510 |  |  |  | 651,334
Creditors amounts falling due after one year |  |  |  | - |  |  |  | (100,000)
Net assets |  |  |  | 516,510 |  |  |  | 551,334
Capital and reserves |  |  |  |  |  |  |  |
Called up share capital |  |  |  | 300 |  |  |  | 300
Profit and loss account |  |  |  | 516,210 |  |  |  | 551,034
Shareholders' funds |  |  |  | 516,510 |  |  |  | 551,334

- The company was entitled to exemption from audit for this reporting period under section 477 of the Companies Act 2006 relating to small companies.
- The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
- The Directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
- These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.
- The directors have chosen to not file a copy of the company’s profit and loss account under section 444 (5A) Companies Act 2006.

The financial statements were approved and authorised for issue by the Board of Directors on 4 September 2025, and are signed on its behalf by:
Darryl Miles Cassingham Director Registered Company No. 11258426

VORLON RESEARCH LIMITED
Notes to the Financial Statements
for the year ended 31 March 2025

1. | Accounting policies
--- | ---

| Statutory information
--- | ---
| The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

| Statement of compliance
--- | ---
| The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.

| Revenue from sale of goods
--- | ---
| Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.

| Tangible fixed assets and depreciation
--- | ---
| Tangible fixed assets are stated at cost or valuation less depreciation. Depreciation is provided on all tangible fixed assets as follows:

|  | Reducing balance (%)
| Plant and machinery | 20
| Office Equipment | 20

2. | Average number of employees
--- | ---

|  | 2025 |  | 2024
| Average number of employees during the year | 0 |  | 0

3. | Tangible fixed assets
--- | ---

|  | Plant & machinery |  | Office Equipment |  | Total
--- | --- | --- | --- | --- | --- | ---
|  | £ |  | £ |  | £
| Cost or valuation
| At 01 April 24 | 179,125 |  | 5,013 |  | 184,138
| Additions | 60,464 |  | 4,179 |  | 64,643
| At 31 March 25 | 239,589 |  | 9,192 |  | 248,781
| Depreciation and impairment
| At 01 April 24 | 64,939 |  | 757 |  | 65,696
| Charge for year | 30,556 |  | 1,331 |  | 31,887
| At 31 March 25 | 95,495 |  | 2,088 |  | 97,583
| Net book value
| At 31 March 25 | 144,094 |  | 7,104 |  | 151,198
| At 31 March 24 | 114,186 |  | 4,256 |  | 118,442

4. | Debtors: amounts due within one year
--- | ---

|  | 2025 |  | 2024
--- | --- | --- | --- | ---
|  | £ |  | £
| Trade debtors / trade receivables | 4,069 |  | 2,400
| Amounts owed by group undertakings | 201,152 |  | 58,847
| Total | 205,221 |  | 61,247

| Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.

5. | Creditors: amounts due within one year
--- | ---

|  | 2025 |  | 2024
--- | --- | --- | --- | ---
|  | £ |  | £
| Trade creditors / trade payables | 9 |  | -
| Amounts owed to related parties | 40,020 |  | 48,520
| Taxation and social security | 1,138 |  | 4,444
| Accrued liabilities and deferred income | 799 |  | 750
| Total | 41,966 |  | 53,714

| Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.